Information;Judgment — ECLI:EU:T:2025:427
Date: 2025-04-30
Language of the case: German
Court formation: Eighth Chamber
Subject matter: Trade marks;Intellectual, industrial and commercial property
Procedure: Action for annulment - unfounded;Action for annulment
Origin: Germany

Judgment of the General Court of 30 April 2025 – Serana Europe v EUIPO – Cytogen Produkte für Medizin + Forschung (Lymphogrow) (Case T-250/24) 1 (EU trade mark – Opposition proceedings – Application for EU word mark Lymphogrow – Non-registered earlier signs Lymphogrow – Relative ground for refusal – Use in the course of trade of a sign of more than mere local significance – Article 8(4) of Regulation (EU) 2017/1001) Language of the case: German Parties Applicant: Serana Europe GmbH (Pessin, Germany) (represented by: T. Bösling and I. George, lawyers) Defendant: European Union Intellectual Property Office (represented by: D. Stoyanova-Valchanova, acting as Agent) Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Cytogen Produkte für Medizin + Forschung GmbH (Greven, Germany) (represented by: C. Röhl, J. Haßold and P. Richnow, lawyers) Re: By its action under Article 263 TFEU, the applicant seeks the annulment and the alteration of the decision of the Second Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 12 March 2024 (Case R 1707/2023-2). Operative part of the judgment The Court: 1. Dismisses the action; 2. Orders Serana Europe GmbH to bear its own costs and to pay those incurred by CYTOGEN – Produkte für Medizin + Forschung GmbH; 3. Orders the European Union Intellectual Property Office (EUIPO) to bear its own costs. ____________ 1 OJ C C/2024/3801, 24.6.2024.